Kedoya Adyaraya Tbk PT Cash Flow Conversion Efficiency
Kedoya Adyaraya Tbk PT cash flow conversion efficiency. Based on the latest financial reports, Kedoya Adyaraya Tbk PT (RSGK) has a cash flow conversion efficiency ratio of -0.005x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-3.71 Billion ≈ $-217.33K USD) by net assets (Rp806.73 Billion ≈ $47.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Kedoya Adyaraya Tbk PT (2018–2024)
Cash flow conversion efficiency of Kedoya Adyaraya Tbk PT from 2018 to 2024. This chart illustrates how Kedoya Adyaraya Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Kedoya Adyaraya Tbk PT for real-time trading data and today's change.
Kedoya Adyaraya Tbk PT Cash Flow Conversion Ratio Explained
Kedoya Adyaraya Tbk PT cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Kedoya Adyaraya Tbk PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kedoya Adyaraya Tbk PT ranked by their cash flow conversion efficiency. Also see Kedoya Adyaraya Tbk PT market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hwacheon Machi
KO:010660
|
-0.024x |
|
Meta Biomed Co. Ltd
KQ:059210
|
0.009x |
|
International Conveyors Limited
NSE:INTLCONV
|
-0.015x |
|
ARSS Infrastructure Projects Limited
NSE:ARSSINFRA
|
-4.896x |
|
Microsemi Corporation
F:MS7
|
2.765x |
|
Mink Therapeutics Inc
NASDAQ:INKT
|
0.148x |
|
Hyweb Technology Co Ltd
TWO:5212
|
0.387x |
|
Sleep Cycle AB
ST:SLEEP
|
0.093x |
Annual Cash Flow Conversion Efficiency for Kedoya Adyaraya Tbk PT (2018–2024)
The table below shows the annual cash flow conversion efficiency of Kedoya Adyaraya Tbk PT from 2018 to 2024. Review Kedoya Adyaraya Tbk PT (RSGK) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp798.46 Billion ≈ $46.79 Million |
Rp81.80 Billion ≈ $4.79 Million |
0.102x | +173.09% |
| 2023-12-31 | Rp751.16 Billion ≈ $44.02 Million |
Rp28.18 Billion ≈ $1.65 Million |
0.038x | -55.19% |
| 2022-12-31 | Rp815.53 Billion ≈ $47.79 Million |
Rp68.28 Billion ≈ $4.00 Million |
0.084x | -17.61% |
| 2021-12-31 | Rp841.81 Billion ≈ $49.33 Million |
Rp85.54 Billion ≈ $5.01 Million |
0.102x | +122.58% |
| 2020-12-31 | Rp487.73 Billion ≈ $28.58 Million |
Rp22.27 Billion ≈ $1.30 Million |
0.046x | +534.93% |
| 2019-12-31 | Rp475.34 Billion ≈ $27.85 Million |
Rp3.42 Billion ≈ $200.27K |
0.007x | -83.96% |
| 2018-12-31 | Rp283.89 Billion ≈ $16.63 Million |
Rp12.72 Billion ≈ $745.51K |
0.045x | -- |
About Kedoya Adyaraya Tbk PT
PT Kedoya Adyaraya Tbk owns and operates hospitals in Indonesia. The company offers facilities, such as inpatient and outpatient room, operating room, delivery room, HCU, ICU, ICCU, PICU, NICU, emergency room, inpatient, outpatient, covid ICU isolation, endoscopy, operating room, sterilization service center installation, and delivery room. It also provides medical support services, including pha… Read more